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hypoglycemic agents or insulin therapy and also had glycosylated hemoglobin (HbA1c) concentration above 7.0%. Twenty-three patients without DM undergoing elective OPCAB matched for age, weight, height, sex, severity of CAOD, left ventricular ejection fraction and educational level were also included (control group). Patients with a history of stroke, neurological or psychiatric illness, renal disease, active liver disease, congestive heart failure, peripheral artery obstructive disease, and carotid artery stenosis over 60% narrowing by carotid duplex ultrasonography scans were excluded. Patients who needed aortic sideclamping for proximal anastomosis of coronary artery were also excluded to rule out the possibility of cerebral emboli by this maneuver.
On the day of surgery, all patients were premedicated with intramuscular injection of morphine 0.05 mg/kg. In the operating room, standard monitoring devices were applied including a pulmonary arterial catheter (Swan-Ganz CCOmbo CCO/SvO2, Edwards Lifesciences LLC, Irvine, CA, USA), which was inserted through the right internal jugular vein before induction of anesthesia. This was connected to an analysis system (Vigilance, Edwards Lifesciences LLC, CA, USA) for continuous monitoring of cardiac index (CI) and mixed venous oxygen saturation (SvO2).
Anesthesia was induced with midazolam 0.05 mg/kg, sufentanil 1.5-3.0 g/kg, and rocuronium bromide 0.9 mg/kg was administered to facilitate endotracheal intubation. Anesthesia was maintained with continuous infusion of sufentanil (0.5-1.5 g· kg -1 · h -1 ), vecuronium bromide (1.0-2.0 g· kg -1 ·min -1 ) and isoflurane (less than 1.0%) in 50% oxygen with air.
The depth of anesthesia was monitored with bispectral index score (BIS) monitor (A-2000, Aspect Medical System Inc, Newton, MA, USA) and BIS was maintained between 40 and 60.
After induction of anesthesia, the transesophageal echocardiography probe was inserted to detect newly developing segmental wall motion abnormalities. Intravascular volume replacement was managed with crystalloid and colloid solutions to maintain the pulmonary capillary wedge pressure between 8 and 14 mmHg according to the baseline values before the displacement of the heart. Central temperature measured by pulmonary artery catheter was maintained between 36.0 and 37.0°C with warm mattress, forced warm air blanket and fluid warmer as necessary. Allogenic packed red blood cells were transfused when the hematocrit concentration was <25% for patients ≥65 years of age and when the hematocrit concentration was <23% for patients <65 years of age throughout the study period. Isosorbide dinitrate (0.5 g·kg -1 ·min -1 ) was infused in all patients and blood glucose concentration was maintained between 80 and 150 mg/dl with intravenous insulin administration as necessary.
All surgical procedures were carried out by one surgeon through a median sternotomy and the heart was displaced using posterior pericardial stitch, large (12×70 cm) gauze swabs and tissue stabilizer (Octopus Tissue Stabilization System, Medtronic Inc, Minneapolis, MN, USA). During the period of heart displacement, mean systemic arterial pressure (MAP) was maintained above 70 mmHg either with 10-20°Trendelenburg position and/or norepinephrine infusion.
Measurement of CVR-CO2
For continuous monitoring of the SjvO2, 4.0F fiberoptic oximetry catheter (Dual-Lumen Oximetry catheter, Edwards Lifesciences LLC, CA, USA) was inserted into the left internal jugular vein in the cephalad direction via the modified Seldinger technique until resistance was sensed at the jugular bulb. The catheter was withdrawn approximately 3-5 mm from the resistant position. The positioning of the jugular bulb catheter tip was verified by radiograph. The correctly positioned catheter tip should lie cranial to a line extending from the atlanto-occipital joint space and caudal to the lower margin of the orbit. This catheter was connected to another analysis system (Vigilance) and calibrated in vivo by drawing a blood sample from the catheter. SjvO2 values were collected and processed in a computer monitor interface, and were displayed every 5 s. Cerebral desaturation was defined as SjvO2 less than 50% over 5 min.
During harvesting of the internal mammary artery, ventilation was adjusted to maintain PaCO2 45±2 mmHg (time T1) for 10 min and the SjvO2 value was recorded. Thereafter, hyperventilation was induced until PaCO2 was reduced to 35±2 mmHg and maintained for 10 min before recording SjvO2 value (time T2). The changes of SjvO2 (∆SjvO2) and that of PaCO2 (∆PaCO2) were measured between time T1 and T2. The CVR-CO2, expressed as the percentage change in SjvO2 per a 1 mmHg change in PaCO2 (∆SjvO2/∆PaCO2), was calculated. After then, ventilation was controlled to maintain PaCO2 35±2 mmHg throughout the surgery.
Measurements of Physiologic Variables
Physiologic variables including MAP, heart rate, mean pulmonary artery pressure, central venous pressure (CVP), CI, SvO2 and SjvO2 were recorded just before the manipulation of the heart (baseline), at 10 min after the application of the tissue stabilizer on the left anterior descending coronary artery, left circumflex coronary artery (LCX) and right coronary artery (RCA) and at skin closure. In addition, the value of the lowest SjvO2 and the number of patients with SjvO2 below 50% for 1-5 min and over 5 min during each coronary arterial anastomosis were recorded. Hematocrit concentration was assessed at each time point of measurement.
Measurements of Neurocognitive Function
All patients underwent a set of neurocognitive tests the day before operation and postoperative day (POD) 2 and 7. The examiner who administered the cognitive tests was unaware of whether patients were in the DM or control group. Neurocognitive function was tested with Mini-Mental State Examination (MMSE), Trail-Making Test (Part A) and Grooved Pegboard Test. MMSE tests the neurocognitive function such as orientation, registration, attention and calculation, recall and language. Trail-Making Test (Part A) and Grooved Pegboard Test examine complex visuo-motor coordination. To obtain an indicator of outcome, overall significant impairment was defined as a decline from preoperative testing of more than 20% reduction at least 1 of 3 test measures. Major neurologic defects (defined as clinical evidence of focal cerebral infarction including hemiparesis, visual or gait disturbance; mental changes such as confusion, agitation, inability to make contact with other people) were also evaluated after surgery.
Statistical Analysis
The sample size calculation was based on the previous similar study 12 that the SjvO2 value in diabetic patients would be decreased by 10% compared with that in control patients with standard deviation of 10% during coronary artery grafting. For an alpha error of 0.05 and power of 90%, a total of 23 patients per group were found to be necessary.
Data were analyzed with SPSS (version 12.0, SPSS Inc, Chicago, IL, USA) and expressed as mean ± standard deviation or number of patients. X 2 -test or Fisher's exact test was performed to compare the patient characteristics and the number of patients with SjvO2 below 50% between the groups. Unpaired t-test was used to compare the difference in SjvO2 and hemodynamic variables between the 2 groups. Repeated measures of analysis of variance was used to compare the difference in hemodynamic variables and SjvO2 within each group. A p-value of less than 0.05 was considered statistically significant.
Results
Patients' characteristics and operative data are summarized in Table 1 . There were no significant differences in demographic data except HbA1c and fasting blood sugar. Mean duration of DM was 12.0±7.7 years, and 4 patients were treated with insulin and remaining patients were treated with oral hypoglycemic agents in the DM group. The CVR-CO2 was similar between the 2 groups ( Table 2) .
Hemodynamic variables, hematocrit concentration and SjvO2 of baseline and 10 min after the application of the tissue stabilizer during each coronary artery anastomosis are listed in Table 3 . Although CI, SvO2 and MAP significantly decreased compared to baseline values during LCX and RCA anastomoses in both groups, there were no significant differences between the groups. SjvO2 significantly decreased compared to baseline values during LCX anastomosis in the control group and during RCA anastomosis in the DM group without significant difference between the groups. Hematocrit concentration was also decreased during the surgery compared to baseline values in both groups without significant intergroup differences. The total amount of infused norepinephrine during the surgery was larger in the DM group without statistical significance (119±151 g and 220±224 g in the control and DM group, respectively, p=0.08).
The duration of each coronary artery anastomosis, the lowest SjvO2 value, and the number of patients with SjvO2 less than 50% for 1-5 min and over 5 min during each coronary artery anastomosis were not different between the 2 groups ( Table 4) .
None of the patients developed major neurological deficits postoperatively. All neurocognitive test scores were comparable between the groups before and after surgery. Scores in MMSE and Trail-Making test did not significantly change after surgery compared to baseline scores in both groups. The time taken to complete Grooved Pegboard Test was significantly increased at POD 2 in both groups compared to baseline values, which returned to the baseline value at POD 7. It was prolonged more than 20% of the baseline in 4 and 6 patients in the control and DM group, respectively at POD 2, but returned to baseline level in all patients at POD 7 (Table 5) .
Discussion
In this prospective trial we could observe that the balance between cerebral blood flow and metabolic rate could be well maintained in diabetic patients to a similar degree as in non-diabetic patients during OPCAB. These observations were irrespective of an accompanying decrease in CI and SvO2 during grafting while PaCO2 and MAP were kept constant within the normal range. Accordingly, none of the patients developed early postoperative neurocognitive dysfunction.
Diabetic patients represent an important subgroup population who undergo cardiac surgery, and compared with nondiabetic patients, they have a variety of increased morbid events, including neurologic complications. 16, 17 One of the possible causes of increased postoperative neurologic deficits in diabetic patients is impaired cerebrovascular circulatory and vasodilatory reserve. 18, 19 Hyperglycemia leads to impaired vascular function by altering endothelial cell function. The pathway that appears most affected by DM is that of nitric oxide 20 and CPB might alter the cerebral endothelial function more extensively in diabetic patients than in non-diabetic patients. 12 As a result, diabetic patients lose the normal coupling of cerebral blood flow with metabolism during CPB and usual cerebral blood flow-perfusion pressure relationship. 7 CVR-CO2 has significant correlation with cerebral autoregulatory index and diabetic patients with reduced CVR-CO2 were reported to have a tendency to have a cerebral desaturation state. 21 As a result of such impairment of cerebrovascular function, in a series of studies observing cerebral oxygenation with SjvO2, diabetic patients more often experienced cerebral desaturation (<SjvO2 50%) than non-diabetic patients during CPB. 7, 12 Cerebral desaturation during CPB is also reported to be closely related to postoperative neurological disorder. 22 Considering that impaired cerebrovascular function in diabetic patients are mostly related to CPB and use of CPB is the only predictor of short-term cognitive dysfunction after CABG, 23 OPCAB could exert beneficial effect in terms of cerebral oxygenation in patients with DM. However, there are no prospective, controlled trials to support this hypothesis by far.
As our results indicate, CVR-CO2 representing cerebral autoregulatory index and SjvO2 were all well maintained in diabetic patients to a similar degree as in non-diabetic patients during OPCAB. Furthermore, there were no differences in SjvO2 and frequency of cerebral desaturation between diabetic and non-diabetic patients during grafting when CI and SvO2 were significantly decreased as a consequence of mechanical displacement of the heart and temporary coronary hemostasis. This can be explained by the fact that many cardiovascular risk factors are present long before the development of diabetes has led to increasing support for the 'common ground' hypothesis in which type 2 diabetes, and cardiovascular disease share common genetic and environmental antecedents. 24 Therefore, DM itself can be considered as not a factor affecting the cerebrovascular reserve in patients with CAOD, but rather be a co-factor augmenting the effect of a trigger factor, which damages vascular reactivity, such as CPB. The result of the current study could be a possible explanation for the previous report that OPCAB in diabetic patients significantly decreased the incidence of postoperative neurologic complication when compared with CABG under CPB. 25 Estimation of cerebral oxygenation during surgery is difficult to achieve. Among devices that measure cerebral oxygenation, SjvO2 estimates global cerebral oxygenation and can be used in anesthetized patients during the surgery. 8, 9 The normal range of SjvO2 is 60-75% and currently used definition of abnormal SjvO2 is less than 50% over 5 min. Cerebral oxygenation is determined by the coupling between cerebral blood flow and metabolic rate, and SjvO2 reflects global cerebral blood flow provided that the cerebral metabolic rate remains constant. In the current study, because BIS between the 2 groups were similar and kept between 40 and 60, the cerebral metabolic rate was assumed to be kept constant during surgery without intergroup difference. Cerebral desaturation is known to be closely related to postoperative neurological disorder in cardiac surgery. 10, 22 Although the time taken to perform Grooved Pegboard Test was significantly prolonged at POD 2 in both groups and some patients showed neurocognitive dysfunction in that test, it is not surprising that none of the patients developed clinically significant neurocognitive dysfunction in the early postoperative period. Our results are quite different from the study of Lee et al, 13 which reported the incidence of neurocognitive dysfunction as 16% at postoperative 2 weeks even in 30 non-diabetic patients undergoing OPCAB. Possible explanations for the discrepancy between the results are avoidance of aortic manipulation and relatively wellmaintained SjvO2 in the present study. In our institution, most cases of OPCAB are done by 'no-touch aortic technique' using total arterial grafts. As aortic side-clamping might result in embolism, we had excluded patients who required aortic side-clamping to confine the factors affecting cerebral oxygenation during OPCAB and postoperative neurocognitive function. In addition, maintaining MAP above 70 mmHg could have played an important role. Usually, most significant hemodynamic changes occur during grafting at the posterior wall of the heart and Trendelenburg position is often required to augment ventricular filling, as well as to optimize surgical exposure. This results in significant increase in CVP as observed in the current study also. Cerebral perfusion pressure is normally determined by MAP and intracranial pressure which is usually well below 15 mmHg. Indeed, Trendelenburg position is associated with increase in regional cerebral oxygenation by augmenting cerebral blood flow; 26 however, when the CVP is increased to a level above the intracranial pressure, cerebral perfusion pressure becomes more dependent on MAP and CVP. The mean CVP during RCA grafting were above 13 mmHg in both groups with some patients having a CVP higher than 15 mmHg. Under these circumstances, when the MAP is maintained at 60 mmHg or lower, cerebral perfusion pressure would be less than 45 mmHg, which could be below the normal limit of cerebral autoregulation in some susceptible patients jeopardizing cerebral oxygenation. In the current study, 3 patients of each group showed cerebral desaturation, and their lowest SjvO2 was 42% and 44% in the DM and control group, respectively. This was accompanied by a decrease in CI, SvO2 and MAP in both groups. However, CI and SvO2 were near the lower normal limit and MAP was maintained above 70 mmHg. As a result, cerebral desaturation rarely developed without intergroup differences. Because only SjvO2 of below 40% resulted in neurocognitive dysfunction after OPCAB in a previous study, 27 maintaining lowest SjvO2 above 40% during the entire coronary artery anastomosis through maintenance of hemodynamic parameters, especially MAP, could also reduce the chance of developing postoperative neurocognitive dysfunction, as in this study.
HbA1c in diabetic patients indicates how the blood sugar concentration was controlled for the past 2-3 months and it has been demonstrated that HbA1c predicts micro-as well as macroangiopathy in diabetic patients, indicating that the primary cause of disturbed cerebrovascular microcirculation is hyperglycemia itself, rather than the severity of DM. 28 Indeed, increased HbA1c was associated with decrease in SjvO2 during CPB and with cognitive impairment at 6 months after CABG, confirming the strong correlation between the severity of microangiopathy in diabetic patients and increased HbA1c. 29, 30 As we had included only patients with HbA1c higher than 7.0% in the diabetic group, the HbA1c in the current study was higher than that of previous studies observing cerebral oxygenation in diabetic patients. This further supports that OPCAB exerts favorable effects with regard to cerebral oxygenation in patients with relatively uncontrolled DM and that it may be considered as an alternative surgical technique for patients with DM and at increased risk for postoperative neurological deficits requiring CABG. However, despite the strong correlation between HbA1c and the presence of angiopathy, [28] [29] [30] whether the results of the present study could also be applied to patients with evident DM complications, such as retinopathy and/or nephropathy, is beyond the scope of this study and remains to be validated.
The limitation of the current study is as follows. This study was designed to focus primarily on the effect of DM on cerebral desaturation measured with SjvO2 during OPCAB and sample size was decided according to that. However, we were unable to draw a correlation between cerebral desaturation and postoperative neurocognitive dysfunction, which was the secondary endpoint of this study, because none of the patients developed neurocognitive dysfunction postoperatively. Therefore, we can only presume that avoiding CPB could have a beneficial effect in terms of neurologic outcome in diabetic patients based on the well-preserved SjvO2 shown in the current study and the association of cerebral desaturation with neurologic outcome reported in previous studies. 10, 22 Further studies evaluating the relationship between SjvO2 and postoperative neurocognitive dysfunction in diabetic patients undergoing OPCAB with a sufficient sample size is required.
In conclusion, the cerebral oxygenation measured with SjvO2 in diabetic patients was similar to that of non-diabetic patients and well maintained above the critical level during OPCAB without resulting in clinically significant postoperative neurocognitive dysfunction.
